Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04880239 · ClinicalTrials.gov registry record · NA
REDUCE Trial- Reducing Prolapse Recurrence
A NA study of Prolapse; Female, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04880239: Recruiting NA study of Prolapse; Female, sponsored by Northwestern University.
NCT04880239 is a NA study of Prolapse; Female that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 200 participants, above the 95-participant average among 3 other Prolapse; Female trials with a reported enrollment target (111% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04880239, a NA study of Prolapse; Female, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether surgeons should add a prophylactic posterior colpoperineorrhaphy to a mesh-augmented apical prolapse repair.
Primary Outcome
The POP-Q System will be used to compare the rate of prolapse recurrence at 1 year between women undergoing a sacrocolpopexy with Restorelle mesh with and without a concomitant posterior colpoperineorrhaphy.
Conditions Studied
Interventions
- PROCEDURE Posterior colpoperineorrhaphy
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-11-23 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What NCT04880239 shows while recruiting
NCT04880239 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 95-participant average among 3 other Prolapse; Female trials with a reported enrollment target (111% higher).
The record links to 1 condition, with Prolapse; Female appearing as the primary indexed condition, and to 1 intervention - of which Posterior colpoperineorrhaphy is the first listed.
NCT04880239 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04880239 about?
NCT04880239 is a clinical study titled "REDUCE Trial- Reducing Prolapse Recurrence". This study will examine whether surgeons should add a prophylactic posterior colpoperineorrhaphy to a mesh-augmented apical prolapse repair.
What is the current status of trial NCT04880239?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-11-23. Estimated completion is 2026-07-30.
What conditions does trial NCT04880239 study?
This clinical trial studies the following conditions: Prolapse; Female.
What interventions are being tested in trial NCT04880239?
The interventions under investigation include: Posterior colpoperineorrhaphy (PROCEDURE).
Who is sponsoring clinical trial NCT04880239?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04880239 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prolapse; Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI